Skip to main content

Reflections from the 2025 International Neuromuscular Symposium

Bridging science and practice

April 10, 2025

By Jen Sanders, Director of Clinical & Medical Affairs at Senzime

Image

Last week, I had the privilege of attending the 2025 International Neuromuscular Symposium—an inspiring and collaborative gathering of global thought leaders in anesthesia.

Held in Budapest, the meeting brought together renowned clinicians, researchers, and implementation experts from over a dozen countries—united by a shared goal: improving patient safety through quantitative neuromuscular monitoring. 

Image
A call to action: Patient safety and implementation science

The symposium opened with a powerful reminder: Despite decades of research, quantitative neuromuscular monitoring remains underutilized in clinical practice.

Dr. Johannes Wacker’s keynote was particularly impactful, emphasizing that up to 50% of perioperative harm is preventable. Residual neuromuscular block (rNMB) and postoperative pulmonary complications (PPCs) remain significant—yet addressable—contributors to patient harm.

From evidence to action: Tackling the implementation gap

Several discussions focused on why quantitative neuromuscular monitoring adoption has been so slow. The reasons are multifactorial—outdated habits, inconsistent guidelines, limited training, and general resistance to change. Fortunately, the proposed solutions were equally clear.

Highlights included:

•    Mandating quantitative neuromuscular monitoring as a standard of care
•    Embedding validated Quality Indicators (QIs) into hospital frameworks
•    Prioritizing resident education and hands-on training

It was energizing to witness the collective momentum behind these ideas. The message resonated: we need champions at every level—international, national, and local—to make meaningful change.

Consensus statement

One of the most exciting developments was the group’s commitment to developing an international consensus statement using the Delphi method. This statement will serve as a guiding framework for clinical implementation, education, and ongoing research. It marks a pivotal step toward global alignment on best practices in neuromuscular management.

With such widespread international alignment, we have an opportunity to translate global consensus into everyday clinical practice.

—Dr. Sorin Brull

Key takeaways
  1. Moving from evidence to everyday use– The evidence supporting quantitative neuromuscular monitoring is robust. Now, we must focus on adoption through cultural change and workflow integration. 
     
  2. Validated QIs are essential – “If you can’t measure it, you can’t improve it.” Standardized, patient-centered QIs are urgently needed.
     
  3. Young clinicians will lead the way – Mentorship and hands-on training for early-career professionals are vital to driving long-term adoption.
     
  4. The time to act is now – With so much international momentum, we have a rare opportunity to turn consensus into clinical reality.
Image
Looking ahead

Planning is already underway for the next symposium, potentially aligned with ESAIC 2026. The proposed format is a two-day event featuring lectures and hands-on workshops. It will focus on implementation science and practical education, especially for early-career professionals eager to lead change.

I left the symposium feeling energized, hopeful, and even more committed to Senzime’s vision: A world where every clinician is empowered and every patient assured.

Author of this blog
Any questions? Feel free to contact me

Jen Sanders, Director of Clinical & Medical Affairs at Senzime

[email protected]

Image
You might also be interested in:
Sugammadex: NOT your silver bullet! Why monitoring still matters

Blog by Dr. Grant Rodney,  Consultant Anaesthetist, Dundee, NHS Tayside, Scotland

Expert Insights: Perspectives on the new guidelines for neuromuscular blockade management

Thoughts from two leading anesthesia experts: Sorin J. Brull, MD, FCARCSI (Hon) and Lars I. Eriksson, MD, PhD, FRCA.

Product demo of next-generation TetraGraph

9-minute overview of the next-generation TetraGraph

What Post-Tetanic Count (PTC) means and why it matters in quantitative TOF monitoring

Blog by Sorin J. Brull, MD, FCARCSI (Hon)

Jen Sanders, Director of Clinical & Medical Affairs at Senzime |